Phillips J H, Weiss A, Gemlo B T, Rayner A A, Lanier L L
Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043.
J Exp Med. 1987 Nov 1;166(5):1579-84. doi: 10.1084/jem.166.5.1579.
After culture in IL-2, thymocytes expressing either TCR-alpha/beta or -gamma/delta acquired the ability to lyse hematopoietic and solid tumor cell targets without deliberate immunization or apparent restriction by the MHC. Moreover, TCR-alpha/beta- and TCR-gamma/delta-bearing thymic cell lines demonstrated an essentially identical spectrum of cytolysis against several tumor cell targets. Cytotoxicity was not inhibited by antibodies against CD3 or CD2 and modulation of the CD3/TCR complex also failed to affect cytotoxicity. Thus, non-MHC-restricted cytotoxicity can be mediated by thymocytes with either TCR-alpha/beta or TCR-gamma/delta, but the TCR may not be responsible for target recognition.
在白细胞介素-2中培养后,表达TCR-α/β或-γ/δ的胸腺细胞获得了裂解造血和实体瘤细胞靶标的能力,无需特意免疫或受主要组织相容性复合体的明显限制。此外,携带TCR-α/β和TCR-γ/δ的胸腺细胞系对几种肿瘤细胞靶标的细胞溶解谱基本相同。细胞毒性不受抗CD3或抗CD2抗体的抑制,CD3/TCR复合体的调节也未能影响细胞毒性。因此,非主要组织相容性复合体限制的细胞毒性可由表达TCR-α/β或TCR-γ/δ的胸腺细胞介导,但TCR可能不负责靶标识别。